Antiviral Repurposing
Antiviral Repurposing is a natural product repurposing strategy that involves the identification and redirection of existing bioactive compounds, originally derived from natural sources and intended for non-antiviral purposes, toward the inhibition or treatment of viral infections through mechanisms such as viral entry blockade, replication interference, or host immune modulation.
71
Publications
6.3K
Citations
562
Authors
230
Institutions
Publications per year
2017–2026
65
Parents
71
Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing
Laura Riva, Shuofeng Yuan, Xin Yin et al. · Nature · 2020 · 856 citations · Full text
Coronavirus puts drug repurposing on the fast track
Charlotte Harrison · Nature Biotechnology · 2020 · 511 citations
Rapid repurposing of drugs for COVID-19
R. Kiplin Guy, Robert S. DiPaola, Frank Romanelli et al. · Science · 2020 · 333 citations
1–5 of 71
562
2
h-index
2
h-index
2
h-index
2
h-index
2
h-index
1–5 of 562
230

King Saud University
Riyadh, Saudi Arabia
4 h-index
9 publications
329 citations
Inserm
Paris, France
3 h-index
22 publications
854 citations

Centre National de la Recherche Scientifique
Paris, France
3 h-index
18 publications
853 citations
Collaborations Pharmaceuticals (United States)
Raleigh, United States
2 h-index
8 publications
256 citations

Leiden University Medical Center
Leiden, The Netherlands
2 h-index
20 publications
1.5K citations
Scripps Research Institute
San Diego, United States
2 h-index
3 publications
1.7K citations
International Center for Chemical and Biological Sciences
Karachi, Pakistan
2 h-index
7 publications
143 citations
University of Pennsylvania
Philadelphia, United States
2 h-index
17 publications
3.9K citations
1–8 of 230
4 publications · 121 citations
4
h-index
Repository · 3 publications · 50 citations
3
h-index
IJMS · 3 publications · 46 citations
3
h-index
Repository · 3 publications · 114 citations
3
h-index
Repository · 2 publications · 75 citations
2
h-index
1–5